Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
74.90
-4.10 (-5.19%)
At close: Apr 29, 2026

HKG:2659 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23
Market Capitalization
25,75325,280--
Enterprise Value
24,72025,052--
Last Close Price
79.0077.55--
PS Ratio
470.78462.14--
PB Ratio
14.5414.27--
P/TBV Ratio
14.6414.38--
EV/Sales Ratio
-457.97--
Debt / Equity Ratio
0.200.200.210.15
Net Debt / Equity Ratio
-0.58-0.58-0.32-0.28
Net Debt / EBITDA Ratio
3.393.390.971.46
Net Debt / FCF Ratio
2.782.780.950.77
Asset Turnover
0.030.030.01-
Inventory Turnover
0.990.990.18-
Quick Ratio
3.763.762.682.22
Current Ratio
4.124.123.392.49
Return on Equity (ROE)
-30.55%-30.55%-41.77%-
Return on Assets (ROA)
-10.79%-10.79%-19.23%-
Return on Capital Employed (ROCE)
-16.40%-16.40%-30.80%-20.20%
Earnings Yield
-1.71%-1.74%--
FCF Yield
-1.44%-1.47%--
Buyback Yield / Dilution
-8.43%-8.43%-5.82%-
Source: S&P Capital IQ. Standard template. Financial Sources.